Xenetic Biosciences is a biopharmaceutical company focused on advancing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens.
Our XCART platform is a novel CAR T technology engineered to target patient- and tumor-specific neoantigens.
Our proprietary and patented technologies are being utilized to create life-changing therapies.
Nov 15, 2019
Oct 29, 2019
Stay informed about our latest news and updates